Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
This map shows the geographic impact of Mark Agius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Agius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Agius more than expected).
This network shows the impact of papers produced by Mark Agius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Agius. The network helps show where Mark Agius may publish in the future.
Co-authorship network of co-authors of Mark Agius
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Agius.
A scholar is included among the top collaborators of Mark Agius based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mark Agius. Mark Agius is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Agius, Mark, et al.. (2017). A Review of the Epidemiology of Major Depressive Disorder and of its consequences for Society and the individual.. PubMed. 29(Suppl 3). 222–231.21 indexed citations
2.
Wiglusz, Mariusz S., Jerzy Landowski, Wiesław Jerzy Cubała, & Mark Agius. (2015). Overlapping phenomena of bipolar disorder and epilepsy--a common pharmacological pathway.. PubMed. 27 Suppl 1. S177–81.8 indexed citations
3.
Agius, Mark, et al.. (2015). The Doctor Patient Relationship; what if Communication Skills are not used? A Maltese Story.. PubMed. 27 Suppl 1. S34–40.4 indexed citations
4.
Singh, Ranbir, Norma Verdolini, Mark Agius, Patrizia Moretti, & Roberto Quartesan. (2015). Comparison of assessment and management of suicidal risk for acute psychiatric assessment between two state sponsored hospitals in England and Italy.. PubMed. 27 Suppl 1. S292–5.1 indexed citations
5.
Ray, Manaan Kar, Sarah Rae, & Mark Agius. (2015). PROMISE. Beyond frontiers.. PubMed. 27 Suppl 1. S497–8.1 indexed citations
6.
Zaman, Rashid, et al.. (2013). Can we prevent under-diagnosis and misdiagnosis of bipolar affective disorder? Repeat audits to assess the epidemiological change in the caseload of a community mental health team when bipolar disorder is accurately assessed and diagnosed.. PubMed. 25 Suppl 2. S129–34.5 indexed citations
7.
Hankir, Ahmed & Mark Agius. (2012). An exploration of how film portrays psychopathology: the animated documentary film Waltz with Bashir, the depiction of PTSD and cultural perceptions.. PubMed. 24 Suppl 1. S70–6.4 indexed citations
8.
Agius, Mark, et al.. (2011). Co-morbidity of bipolar affective disorder and obsessive compulsive disorder in a Bedford community psychiatry team.. PubMed. 23 Suppl 1. S130–3.7 indexed citations
9.
Agius, Mark, et al.. (2011). Post-traumatic stress disorder (PTSD) treatment experience in Bedford East - audit and reaudit.. PubMed. 23 Suppl 1. S104–9.1 indexed citations
10.
Agius, Mark, et al.. (2011). Prevalence of co-morbid bipolar disorder and migraine in a regional hospital psychiatric outpatient department.. PubMed. 23 Suppl 1. S23–4.9 indexed citations
11.
Agius, Mark, et al.. (2011). An audit to compare patient factors (age, sex, social background & associated physical diagnoses) in people with refractory depression in a Bedfordshire Community Mental Health Team (BCMHT) being augmented with (A) mirtazepine, (B) atypical antipsychotics or (C) both.. PubMed. 23 Suppl 1. S166–70.
12.
Agius, Mark, Catherine Murphy, & Rashid Zaman. (2010). Does shared care help in the treatment of depression?. PubMed. 22 Suppl 1. S18–22.9 indexed citations
13.
Davis, Abigail, Michael James Gilhooley, & Mark Agius. (2010). Using non-steroidal anti-inflammatory drugs in the treatment of depression.. PubMed. 22 Suppl 1. S49–52.12 indexed citations
14.
Agius, Mark, Arunabh Talwar, Suzanne Murphy, & Rashid Zaman. (2010). Issues regarding the delivery of early intervention psychiatric services to the South Asian population in England.. PubMed. 22(2). 266–9.3 indexed citations
15.
Agius, Mark, et al.. (2010). Assessment of self harm in an accident and emergency service - the development of a proforma to assess suicide intent and mental state in those presenting to the emergency department with self harm.. PubMed. 22 Suppl 1. S26–32.9 indexed citations
16.
Agius, Mark, et al.. (2010). An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.. PubMed. 22(2). 350–3.4 indexed citations
17.
Agius, Mark, et al.. (2010). The staging model in schizophrenia, and its clinical implications.. PubMed. 22(2). 211–20.51 indexed citations
18.
Agius, Mark, et al.. (2009). The epidemiology of psychosis in Luton.. PubMed. 21(4). 508–13.2 indexed citations
19.
Agius, Mark, Martin Orr, & Deborah Osborne. (2009). The child as the presenting symptom, and what happens when things go wrong?. PubMed. 21 Suppl 1. 137–41.1 indexed citations
20.
Agius, Mark, et al.. (2005). Basic standards for management of patients with serious mental illness in the community.. PubMed. 17(1-2). 42–57.9 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.